P11. Efficacy and safety of erlotinib in advanced squamous cell lung cancer

BACKGROUND: Erlotinib is epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor which showed efficacy and tolerability in patients with advanced non-small cell lung cancer (NSCLC), especially in group of patients which harbor activating mutations in EGFR. AIM: To determine safety and effi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Lung Cancer Res
Main Authors: Jakopovic, Marko, Cucevic, Branka, Plestina, Sanja, Kukulj, Suzana, Roglic, Mihovil, Smojver-Jezek, Silvana, Korsic, Marta, Redzepi, Gzim, Samarzija, Miroslav
Format: Artigo
Sprog:Inglês
Udgivet: Pioneer Bioscience Publishing Company 2014
Fag:
CELCC 2014 Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367745/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB023
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker